Table 1. Clinical characteristics of IV-tPA treated patients.
NIHSS - National Institutes of Health Stroke Scale, sICH - Symptomatic intracerebral hemorrhage, CEA - Carotid Endarterectomy, NASCET - North American Symptomatic Carotid Endarterectomy Trial
| Patient | Age (years) |
Gender | Admission Medications | NIHSS at admission |
NIHSS after thrombolysis* |
Degree of Carotid Stenosis (NASCET Criteria)1 |
Symptom to CEA interval (days) |
sICH | Other Complications |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Antiplatelet Therapy |
Anticoagulant Therapy |
|||||||||
| 1 | 76 | M | None | None | 0 | 0 | 50 | 2 | No | None |
| 2 | 68 | F | None | None | 7 | 4 | 80 | 10 | No | None |
| 3 | 69 | M | None | None | 0 | 0 | 60 | 1 | No | TIAs |
| 4 | 47 | F | None | None | 10 | 3 | 99 | 2 | Yes | None |
| 5 | 70 | F | Aspirin | None | 6 | 1 | 75 | 3 | Yes (Twice) |
Ventriculitis, Death |
| 6 | 53 | M | None | None | 16 | 23+ | 75 | 49 | No | None |
| 7 | 72 | F | Aspirin | None | 2 | 0 | 85 | 85 | No | None |
| 8 | 61 | M | None | None | 15 | 12 | 80 | 30 | No | None |
| 9 | 72 | M | None | None | - | - | 80 | 21 | No | None |
| 10 | 51 | M | Aspirin | None | 24 | 16 | 85 | 181 | No | None |
| 11 | 56 | M | None | None | 22 | 14 | 95 | 38 | No | None |
*
NIHSS was obtained 24 hours after thrombolysis.
+
Patient had hemorrhagic conversion of ischemic infarct after tPA administration. However, his neurological function improved significantly over the next 6 weeks and he eventually underwent CEA without complications.